WST - West Pharmaceutical Services, Inc.
| Previous Close | 107.75 |
| Open | 108.13 |
| Bid | 106.2600 x 800 |
| Ask | 106.3300 x 900 |
| Day's Range | 106.08 - 108.27 |
| 52 Week Range | 82.74 - 125.09 |
| Volume | 148,683 |
| Avg. Volume | 362,149 |
| Market Cap | 7.911B |
| Beta (3Y Monthly) | 1.45 |
| PE Ratio (TTM) | 52.17 |
| EPS (TTM) | 2.0470 |
| Earnings Date | Feb 13, 2019 - Feb 18, 2019 |
| Forward Dividend & Yield | 0.60 (0.57%) |
| Ex-Dividend Date | 2018-10-23 |
| 1y Target Est | 112.83 |
Markit•3 days agoSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Simply Wall St.•4 days ago
West Pharmaceutical Services Inc (NYSE:WST): What’s In It For The Shareholders?
Two important questions to ask before you buy West Pharmaceutical Services Inc (NYSE:WST) is, how it makes money and how it spends its cash. What is left after investment, determines Read More...
- Simply Wall St.•last month
Is Now The Time To Look At Buying West Pharmaceutical Services Inc (NYSE:WST)?
West Pharmaceutical Services Inc (NYSE:WST), which is in the medical equipment business, and is based in United States, received a lot of attention from a substantial price movement on the Read More...
Markit•last monthSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•last month
HSIC vs. WST: Which Stock Is the Better Value Option?
HSIC vs. WST: Which Stock Is the Better Value Option?
- Thomson Reuters StreetEvents•last month
Edited Transcript of WST earnings conference call or presentation 25-Oct-18 1:00pm GMT
Q3 2018 West Pharmaceutical Services Inc Earnings Call
Markit•last monthSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- GlobeNewswire•last month
Consolidated Research: 2018 Summary Expectations for Aquinox Pharmaceuticals, Xilinx, West Pharmaceutical Services, nVent Electric, World Wrestling Entertainment, and HD Supply — Fundamental Analysis, Key Performance Indications
NEW YORK, Nov. 01, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- PR Newswire•last month
West Announces Participation in Upcoming November Investor Conferences
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management ...
- Zacks•2 months ago
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 7.04% and 0.97%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•2 months ago
West Pharmaceutical: 3Q Earnings Snapshot
The Exton, Pennsylvania-based company said it had profit of 73 cents per share. Earnings, adjusted for non-recurring costs and restructuring costs, were 76 cents per share. The results beat Wall Street ...
- PR Newswire•2 months ago
West Announces Third-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter ...
- PR Newswire•2 months ago
West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide
EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award. The honor was presented to West on October 9, 2018, at the CPhI Worldwide conference in Madrid, Spain. Organized by CPhI Worldwide, one of the world's largest pharma trade shows, the CPhI Pharma Awards recognize innovative pharmaceutical companies who are committed to driving the industry forward.
- PR Newswire•2 months ago
West to Host Third-Quarter 2018 Conference Call
EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 8341499.
- PR Newswire•2 months ago
West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
West named as finalist in CPhI Pharma Awards EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, ...
- PR Newswire•3 months ago
West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award
EXTON, Pa., Sept. 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green, has received the CEO Connection's 2018 Social Impact Award. The honor was presented to Mr. Green at the CEO Connection's Mid-Market Convention Awards Dinner on September 25, 2018, at the University of Pennsylvania Museum of Archaeology and Anthropology, located in Philadelphia, Pennsylvania.
Markit•3 months agoSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc NYSE:WST
- Simply Wall St.•3 months ago
Is West Pharmaceutical Services Inc’s (NYSE:WST) PE Ratio A Signal To Sell For Investors?
I am writing today to help inform people who are new to the stock market and want to begin learning about how to value company based on its current earningsRead More...
- Thomson Reuters StreetEvents•5 months ago
Edited Transcript of WST earnings conference call or presentation 26-Jul-18 1:00pm GMT
Q2 2018 West Pharmaceutical Services Inc Earnings Call
- Associated Press•5 months ago
West Pharmaceutical: 2Q Earnings Snapshot
The Exton, Pennsylvania-based company said it had profit of 75 cents per share. Earnings, adjusted for pretax gains, were 70 cents per share. The results surpassed Wall Street expectations. The average ...
- PR Newswire•5 months ago
West Announces Second-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter ...
- PR Newswire•5 months ago
West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
EXTON, Pa., July 19, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced manufacturing network, and the launch of a new product line—Westar® Select. Customers and senior-level Irish government officials joined West at a ribbon-cutting ceremony to celebrate the facility's opening and to recognize West's ongoing commitment to improving patient lives through their products and services. "West is very pleased to celebrate the official opening of our state-of-the-art facility in Waterford, as well as the launch of Westar Select, both of which are the culmination of efforts by many to support our company's commitment to meeting the dynamic needs of our pharmaceutical and biotech partners," said Eric Green, President and CEO, West.
- CNBC•5 months ago
Cramer's lightning round: Cigna's stock is undervalued considering its latest acquisition
It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Cigna Corporation CI : “OK, when [CEO] David Cordani came on, the stock was right around here. Sociedad Quimica y Minera de Chile S.A SQM-X.A-CL .: “Sociedad Quimica is not an expensive stock if lithium takes off.
- PR Newswire•5 months ago
West to Host Second-Quarter 2018 Conference Call
EXTON, Pa. , July 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release ...
- Simply Wall St.•6 months ago
Why Wistil Spólka Akcyjna (WSE:WST) Should Have A Place In Your Portfolio
Wistil Spólka Akcyjna (WSE:WST) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In theRead More...
